Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancerReport as inadecuate




Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer - Download this document for free, or read online. Document in PDF available to download.

Journal for ImmunoTherapy of Cancer

, 3:P106

First Online: 04 November 2015DOI: 10.1186-2051-1426-3-S2-P106

Cite this article as: Subudhi, S.K., Aparicio, A., Gao, J. et al. j. immunotherapy cancer 2015 3Suppl 2: P106. doi:10.1186-2051-1426-3-S2-P106 Download fulltext PDF



Author: Sumit K Subudhi - Ana Aparicio - Jianjun Gao - Amado Zurita - Araujo John - Christopher Logothetis - Brinda Rao - Luis Ve

Source: https://link.springer.com/







Related documents